• On The Pen Live Eps 67: Survodutide Trial Participant Tells All!
    May 25 2024

    Send us a Text Message.

    In this week’s episode of On The Pen Live, guest Scott Liberto of PlanetScott.com joins to discuss his experience in the Survodutide clinical trial.

    Survodutide is an investigational dual agonist targeting both the glucagon and GLP-1 receptors, developed by Boehringer Ingelheim in collaboration with Zealand Pharma. This novel drug is designed to treat obesity and metabolic dysfunction-associated steatohepatitis (MASH).

    Support the Show.

    MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    SOCIAL LINKS
    https://www.tiktok.com/@manonthemounjaro
    https://twitter.com/ManOnMounjaro
    https://instagram.com/manonthemounjaro
    https://facebook.com/manonthemounjaro

    #Zepbound #releasethevials #mounjaro

    📲 Contact Me: MounjaroMan@gmail.com

    📼 PLAYLISTS:
    🖊️ ON THE PEN LIVES:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
    👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
    https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
    😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
    🚨📰 ALL THE LATEST MOUNJARO NEWS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.

    Show more Show less
    1 hr and 18 mins
  • On The Pen: The Weekly Dose 5.21.24
    May 21 2024

    Send us a Text Message.

    📧 SIGN UP FOR EMAILS: https://www.onthepen.com/emails

    💳 BECOME A MEMBER: Join this channel
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    📰 SEEKING ALPHA ARTICLE: https://seekingalpha.com/news/4092598-tiktok-restrict-weight-loss-drug-promotion

    🎙️PODCAST LINK: https://podcasts.apple.com/us/podcast/on-the-pen-the-weekly-dose/id1725737068

    💵 DONATIONS:
    Venmo: https://venmo.com/u/OnThePen
    Ca$h App: https://cash.app/$ManOnMounjaro
    PayPal: https://www.paypal.me/DavidTKnapp

    SOCIAL LINKS
    https://www.tiktok.com/@manonthemounjaro
    https://twitter.com/ManOnMounjaro
    https://instagram.com/manonthemounjaro
    https://facebook.com/manonthemounjaro

    📲 Contact Me: MounjaroMan@gmail.com

    👉 Link to other GLP-1 MUST HAVE products I mention: https://www.amazon.com/shop/manonthemounjaroonthepen

    📼 PLAYLISTS:
    🖊️ ON THE PEN LIVES:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
    👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
    https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
    😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
    🚨📰 ALL THE LATEST MOUNJARO NEWS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB

    SHOW LINKS:
    Novo Nordisk fire:
    Link: https://www.wsj.com/livecoverage/stock-market-today-dow-jones-earnings-05-16-2024/card/fire-at-novo-nordisk-construction-site-gives-investors-a-scare-eSSAtdDDhxYwUw3bGDZI?mod=lctimeline_finance

    New CagriSema drug trial
    Link: https://clinicaltrials.gov/study/NCT06409130

    Wegovy Heart Benefits:
    Link: https://www.cnn.com/2024/05/13/health/wegovy-trial-analysis/index.html

    CT-488 Phase 1 Results:
    Link: https://www.fiercebiotech.com/biotech/roches-27b-carmot-bet-pays-phase-1-weight-loss-success

    Nothing contained in this podcast is medical advice. Please consult your liscensed physician on all matters pertaining to your health. Any Amazon links are affiliate links, which provide a small percentage of any sale to me as a commission.

    Support the Show.

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

    Show more Show less
    25 mins
  • On The Pen: The Weekly Dose 5.14.24
    May 14 2024

    Send us a Text Message.

    MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    Hello Fresh Free Box:
    https://www.hellofresh.com/pages/raf_lp11?c=FIH-XR3LF83PJ9QE&utm_campaign=referralinvite&utm_medium=clipboard&utm_source=freebies&utm_invitername=David&utm_term=web&discount_comm_id=992270dc-a684-4b10-bd34-da8bb5f811b2

    SOCIAL LINKS
    https://www.tiktok.com/@manonthemounjaro
    https://twitter.com/ManOnMounjaro
    https://instagram.com/manonthemounjaro
    https://facebook.com/manonthemounjaro

    #Zepbound #releasethevials #mounjaro

    📲 Contact Me: MounjaroMan@gmail.com
    👉 Link to other GLP-1 MUST HAVE products I mention: https://www.amazon.com/shop/manonthemounjaroonthepen

    📼 PLAYLISTS:
    🖊️ ON THE PEN LIVES:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
    👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
    https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
    😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
    🚨📰 ALL THE LATEST MOUNJARO NEWS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB

    SHOW NOTES:
    Update on Bernie Sander's fight against high prices for GLP-1 medicationsLink: https://www.msn.com/en-us/health/other/novo-asks-for-more-time-to-answer-sanders-on-ozempic-s-price/ar-BB1lZ0P2

    CFO of Viking Therapeutics sold stock
    Link: https://www.investing.conews/company-news/viking-therapeutics-cfo-sells-over-49-million-in-company-stock-93CH-3419573

    Novo Nordisk bond sale (Bloomberg article):
    Link: https://www.bloomberg.com/news/articles/2024-05-13/ozempic-maker-novo-nordisk-plans-bond-sale-to-fund-expansion?embedded-checkou

    Support the Show.

    MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    SOCIAL LINKS
    https://www.tiktok.com/@manonthemounjaro
    https://twitter.com/ManOnMounjaro
    https://instagram.com/manonthemounjaro
    https://facebook.com/manonthemounjaro

    #Zepbound #releasethevials #mounjaro

    📲 Contact Me: MounjaroMan@gmail.com

    📼 PLAYLISTS:
    🖊️ ON THE PEN LIVES:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
    👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
    https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
    😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
    🚨📰 ALL THE LATEST MOUNJARO NEWS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.

    Show more Show less
    16 mins
  • Threats to Lilly's Zepbound & Mounjaro Printing Press
    May 11 2024

    Send us a Text Message.

    Roche Pharmaceuticals has acquired Carmot Therapeutics along with three obesity and type 2 diabetes candidates: CT-868 / CT-368 / CT-986

    MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    Hello Fresh Free Box:
    https://www.hellofresh.com/pages/raf_lp11?c=FIH-XR3LF83PJ9QE&utm_campaign=referralinvite&utm_medium=clipboard&utm_source=freebies&utm_invitername=David&utm_term=web&discount_comm_id=992270dc-a684-4b10-bd34-da8bb5f811b2

    SOCIAL LINKS
    https://www.tiktok.com/@manonthemounjaro
    https://twitter.com/ManOnMounjaro
    https://instagram.com/manonthemounjaro
    https://facebook.com/manonthemounjaro

    #Zepbound #Maritide #mounjaro

    📲 Contact Me: MounjaroMan@gmail.com
    👉 Link to other GLP-1 MUST HAVE products I mention: https://www.amazon.com/shop/manonthemounjaroonthepen

    📼 PLAYLISTS:
    🖊️ ON THE PEN LIVES:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
    👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
    https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
    😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
    🚨📰 ALL THE LATEST MOUNJARO NEWS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB

    Support the Show.

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

    Show more Show less
    11 mins
  • On The Pen: The Weekly Dose 5.7.24
    May 8 2024

    Send us a Text Message.

    MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    SOCIAL LINKS
    https://www.tiktok.com/@manonthemounjaro
    https://twitter.com/ManOnMounjaro
    https://instagram.com/manonthemounjaro
    https://facebook.com/manonthemounjaro

    #Zepbound #Maritide #mounjaro

    LINKS
    Life Update Blog: Link: https://www.onthepen.com/post/i-m-tired-we-are-tired

    Wegovy released in Canada:
    Link: https://www.msn.com/en-ca/health/other/weight-loss-drug-wegovy-available-in-canada-starting-may-6/ar-AA1o1lZz

    Madison Muller at Bloomberg (friend of our community) had article "Why Weight-Loss Drugs Wegovy, Zepbound Are in Short Supply"
    Link: https://www.bloomberg.com/news/articles/2024-05-02/why-weight-loss-drugs-wegovy-zepbound-are-facing-shortages?srnd=undefined&embedded-checkout=true

    Interviewed on radio station KXEL
    Link: https://www.youtube.com/watch?v=V0YyMwtMuxs

    Optum RX Irony alert:
    Link: https://www.managedhealthcareexecutive.com/view/glp-1-tiering-agreement-reached-says-optum-rx-president

    FTC is challenging Novo Nordisk's patents on Ozempic
    Link: https://www.ftc.gov/system/files/ftc_gov/pdf/novo-nordisk-ozempic-saxenda-victoza-_4302024.pdf

    FTC requested additional information on Novo Nordisk's acquisition of Catalent:
    Link: https://www.msn.com/en-us/money/markets/us-ftc-seeks-more-information-on-novo-nordisk-parent-catalent-deal/ar-AA1o6gHU

    Support the Show.

    MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    SOCIAL LINKS
    https://www.tiktok.com/@manonthemounjaro
    https://twitter.com/ManOnMounjaro
    https://instagram.com/manonthemounjaro
    https://facebook.com/manonthemounjaro

    #Zepbound #releasethevials #mounjaro

    📲 Contact Me: MounjaroMan@gmail.com

    📼 PLAYLISTS:
    🖊️ ON THE PEN LIVES:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
    👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
    https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
    😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
    🚨📰 ALL THE LATEST MOUNJARO NEWS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.

    Show more Show less
    18 mins
  • Lilly Earnings Call: Zepbound and Mounjaro Updates
    May 1 2024

    Send us a Text Message.

    Dave Knapp does a deep dive into todays Eli Lilly earnings call.

    https://www.onthepen.com/post/zepbound-vial-watch-eli-lilly-earnings-q1-2024

    MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    SOCIAL LINKS
    https://www.tiktok.com/@manonthemounjaro
    https://twitter.com/ManOnMounjaro
    https://instagram.com/manonthemounjaro
    https://facebook.com/manonthemounjaro

    Support the Show.

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

    Show more Show less
    28 mins
  • On The Pen: The Weekly Dose 4/30/24
    Apr 30 2024

    Send us a Text Message.

    1.7 mg of Wegovy is no longer in shortage:
    Semaglutide: FDA website updated to show 1.7 mg of Wegovy is no longer in shortage
    Link: https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Semaglutide%20Injection&st=c

    GNC introduces special section for GLP-1 users:
    GNC will have special section for GLP-1 users that will concentrate on four areas: GI Health, Retaining Lean muscle mass, Bone health, Nutritional support
    Link: https://www.gnc.com/learn/newsroom/gnc-semaglutide-support-program.html

    Identified upper dose values in tirzepatide high-dose trial
    20 mg and 25 mg
    Primary Completion in this trial is 12/24/2024 (Merry Christmas) with final completion September 30, 2025
    Link: https://www.onthepen.com/post/higher-doses-of-zepbound-and-mounjaro-being-tested

    US Senator Bernie Sanders investigating the price of Wegovy/Ozempic
    Ozempic costs $936 per month, while Wegovy costs $1,350
    Ozempic costs $155 in Canada, and cost $59 in Germany. This dramatic difference in cost has led to concerns about the accessibility and affordability of these drugs for American patients.
    With the cardiovascular disease indication, millions of additional medicare patients are eligible for taking Wegovy which means billions at the current prices
    Link: https://www.onthepen.com/post/the-price-of-health-bernie-sanders-investigates-ozempic-and-wegovy
    Link: https://www.kff.org/medicare/issue-brief/a-new-use-for-wegovy-opens-the-door-to-medicare-coverage-for-millions-of-people-with-obesity/

    Germany is promoting their pharmaceuticals industry:
    tax breaks, and speeding up clinical trials
    Eli Lilly is investing 2.3 Billion Euros to build a glp-1 manufacturing plant in Germany:
    Link: https://uk.finance.yahoo.com/news/scholz-promises-support-pharma-sector-101833297.html

    Lexaria begins phase 1 trial:
    Lexaria (stock symbol: LEXX) will test their technology to improve stomach absorption of Rybelsus in phase 1 trial (i.e. wouldn't need large 25/50 mg doses if absorption was better).
    They are also testing under tongue (sublingual) absorption of Rybelsus in another phase 1 trial
    Link: https://ir.lexariabioscience.com/news-events/press-releases/detail/246/lexaria-receives-ethics-review-board-approval-to-begin-new

    Viking Therapeutics earnings call
    Planning to start addition phase 2 trial of injectable VikingTide (VK2735) in Q4 of 2024 that will last 6-9 months (If you remember, the first phase 2 trial was only 13 weeks)
    The oral VikingTide (VK2735) phase 1 trial is still investigating higher and higher doses due to the low side effect profile. They expect results in summer of 2024.


    MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    SOCIAL LINKS
    https://www.tiktok.com/@manonthemounjaro
    https://twitter.com/ManOnMounjaro
    https://instagram.com/manonthemounjaro
    https://facebook.com/manonthemounjaro


    Support the Show.

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

    Show more Show less
    16 mins
  • On The Pen: The Weekly Dose 4/23/24
    Apr 23 2024

    Send us a Text Message.

    New obesity medicine company launches, Lilly expands manufacturing capacity with acquisition, and TikTok censors my content.

    Email Alerts: https://www.onthepen.com/emails

    BECOME A MEMBER HERE TO WATCH THE VIDEO:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    New Obesity Medicine Company Launches: https://metsera.com/news
    Lilly Acquires Nexus Facility: https://finance.yahoo.com/news/lilly-buy-injectable-drug-plant-175000782.html
    TikTok Mounjaro Zepbound Censorship: https://www.bloomberg.com/news/articles/2024-04-22/tiktok-ozempic-influencers-say-new-rules-unfairly-target-them

    SOCIAL LINKS
    https://www.tiktok.com/@manonthemounjaro
    https://twitter.com/ManOnMounjaro
    https://instagram.com/manonthemounjaro
    https://facebook.com/manonthemounjaro

    Support the Show.

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

    Show more Show less
    15 mins